PAR-25-288 ED diversion R34 eligibility Guide
Updated 6 official sources
Quick Answer: PAR-25-288 is an active NIMH R34 for pilot testing patient-navigation emergency department diversion models for non-urgent mental health problems.
Full answer and how we checked it
It requires a clinical trial, caps direct costs at $225,000 per year and $450,000 over 3 years, lists February 16, 2027 as the next new-application date (November 16, 2026 for resubmissions), and points larger studies to companion R01 PAR-25-289. The 2026 decision turns on 7 checks.
Who this is for: Child and adolescent mental health researchers, emergency department teams, health services researchers, community mental health partners, patient-navigation model teams, and sponsored-research offices deciding whether a pilot clinical trial fits.
Data note: This guide uses NIH PAR-25-288, companion R01 PAR-25-289, Grants.gov listing 357386, and Grantsights award-data signals first checked on June 2, 2026; NIH due dates were rechecked on October 10, 2026.
In this guide
- October 2026 Source Check
- 7 PAR-25-288 Eligibility Stop Checks
- 5 Source Facts Applicants Should Know
- What NIH Doesn't Tell You
- 6 Evidence Assets That Make This R34 Stronger
- 5 Route Choices Before Drafting
- 6 Bad-Fit Signals
- 21-Day R34 Routing Plan
- 7 Above-the-Fold Claims That Need Proof
- 7 Route Checks Added June 2, 2026
- Sources
PAR-25-288 is not a general emergency department access grant. NIH frames it around patient-navigation models for non-urgent mental health concerns, especially models that triage acuity, support caregivers, connect families to services, address barriers, and test how, why, and for whom the model works.
R34 pilot clinical trial, companion R01 fully powered study, and nonresponsive local program evaluation.
Use this guide with the live Mental Health ED Diversion R34 program record. Then compare NIH grants complete guide, NIH R01 R21 R03 K awards comparison, what is a NOFO, Healthcare Grants Complete Guide, and the Grantsights grant database.
October 2026 Source Check
According to NIH in PAR-25-288 (opens in a new tab), this R34 remains active. The June 16, July 16 and October 16, 2026 dates have passed; the next are November 16, 2026 for resubmissions and February 16, 2027 for new applications, then March 16, 2027 for resubmissions. Applications are due by 5 p.m. local time, and the notice expires January 8, 2028. NIH lists the clinical-trial status as required and the budget limit as $225,000 in direct costs per year, with $450,000 total direct costs over the project period.
According to NIH in PAR-25-289 (opens in a new tab), the companion R01 is for projects with pilot data and a fully powered effectiveness test. That source confirms the route split: PAR-25-288 for pilot testing and mechanism learning, PAR-25-289 for a larger trial.
| October 10 check | Current source read | Applicant action |
|---|---|---|
| Status | Active through January 8, 2028 | Use the live NIH table, not a copied deadline |
| Next new date | February 16, 2027 | Decide now whether June 16, 2027 is more realistic |
| Resubmission date | November 16, 2026 | Check the prior summary statement before routing |
| Trial status | Required | Build the human-subjects and trial record early |
| Route split | R34 pilot versus R01 powered test | Stop if the study is already an R01 |
The date math matters here. The October 16, 2026 new-application date has passed, so the next one is February 16, 2027, then June 16, 2027, with resubmissions due November 16, 2026 and March 16, 2027. A team that hasn't yet drafted its clinical-trial record, human-subjects plan, and data safety monitoring plan may find the June date more realistic. The $450,000 cap on total direct costs over the three-year project period should shape the pilot's size before the first draft starts, and the companion R01, PAR-25-289, is the better home for a team that already has pilot data and wants to run a fully powered effectiveness test.
The $225,000 yearly direct-cost cap also forces a lean staffing plan. A budget that has to cover navigator salaries, emergency department partner time, and trial monitoring should be sketched against that cap before the team commits to a design.
Get grant deadline alerts by email
About once a week, we email a short list of open grant calls with real deadlines from different funders. It isn't limited to the programs in this guide.
No spam. Unsubscribe anytime.
7 PAR-25-288 Eligibility Stop Checks
Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.
7 stop checks decide whether this route fits.
| Stop check | Strong R34 signal | Red flag |
|---|---|---|
| Model | Patient-navigation ED diversion model is central | Usual care quality-improvement project |
| Population | Non-urgent mental health concerns | Acute emergency treatment study |
| Trial status | NIH-defined clinical trial is proposed | No trial design |
| Pilot stage | Signal detection or component testing | Fully powered effectiveness study |
| Mechanism | How, why, and for whom will be tested | Descriptive evaluation only |
| Partnership | Research-practice partnership is specified | Site partner is vague |
| Next route | R01 path is plausible | No next effectiveness question |
This R34 is strongest when the model can be piloted in a real care setting without pretending to be a full effectiveness trial.
5 Source Facts Applicants Should Know
Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.
5 facts should be visible before a user scrolls.
| Fact | Source-backed read |
|---|---|
| Funding number | PAR-25-288 |
| Mechanism | R34 Planning Grant |
| Clinical trial status | Required |
| Budget | Up to $225,000 direct costs per year and $450,000 total |
| Expiration | January 8, 2028 |
NIH says the companion R01 is PAR-25-289 for larger-scale, fully powered studies. According to USAspending.gov (opens in a new tab) data, assistance listing 93.242 had about $1.77B in FY2024 obligations across 6,220 awards active that year.
What NIH Doesn't Tell You
Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.
4 practical issues decide whether the R34 should move forward.
First, the model has to be a navigator model, not a general referral workflow. The intervention should include acuity triage, caregiver support, connection to mental health services, resource linkage, and help with barriers.
Second, this is a clinical trial required route. If the team is not ready to build a trial record, outcome measures, human-subjects plan, and data safety monitoring, it is not ready.
Third, the study should detect a signal, not prove final effectiveness. NIH says projects need not be statistically powered in pilot work but should detect signals of effectiveness.
Fourth, mechanism testing matters. Applications that do not evaluate mechanisms of action and their impact on primary outcomes are nonresponsive. A pilot that only reports feasibility numbers, such as how many families the navigator reached, won't answer the mechanism question NIH asks.
6 Evidence Assets That Make This R34 Stronger
Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.
6 evidence assets make the application stronger. The first is a navigator model map: who delivers it, where, what training is required, what supervision exists, and what the navigator does.
The second is a setting-capacity statement. ED workflow, pediatric mental health access, caregiver needs, and community service capacity should be described plainly.
The third is a trial design memo. It should explain whether the design is randomized, adaptive, factorial, or another pilot design and why it fits the question.
The fourth is a mechanism table. Include engagement, knowledge, barriers, caregiver support, service use, symptoms, ED reuse, and family-level outcomes.
The fifth is a resource table. NIH cares whether the model can be adopted outside research settings. Training time, staff role, delivery burden, supervision, and technology needs should be visible.
The sixth is an R01 bridge. The pilot should explain what signal would justify a fully powered companion-route study.
5 Route Choices Before Drafting
Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.
5 routes should be compared.
| Route | Better first read when... | Why |
|---|---|---|
| PAR-25-288 R34 | Pilot testing and mechanism learning are needed | Route matches pilot stage |
| PAR-25-289 R01 | Study is fully powered | Companion R01 is built for that |
| Parent clinical trial route | Navigator ED diversion is not central | Topic may fit elsewhere |
| Implementation study | Model is already proven and adoption is the question | R34 may be too early |
| Local evaluation | No research mechanism question exists | Not a good NIH fit |
6 Bad-Fit Signals
Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.
6 bad-fit signals should be clear. First, the project does not test a navigator model. Second, the project is a traditional therapeutic or preventive intervention rather than ED diversion navigation.
Third, it is a descriptive evaluation. Fourth, it lacks mechanism testing. Fifth, it is fully powered and belongs in the R01. Sixth, the team cannot describe the practice partnership.
Those stop checks make the page more useful than a title scraper.
21-Day R34 Routing Plan
Within 21 days, use this section as the checkpoint for the ED diversion R34 before a team builds the clinical-trial packet.
Days 1 through 3 should confirm source status, due date, clinical-trial required status, budget, and companion R01 comparison.
Days 4 through 7 should map the navigator model: staff, training, supervision, site workflow, caregiver touchpoints, service links, and resource needs.
Days 8 through 12 should define the pilot trial design and endpoints. State what signal is enough for an R01.
Days 13 through 16 should build the mechanism table. Identify how the model is expected to change engagement, knowledge, barriers, service use, and outcomes.
Days 17 through 21 should prepare the practice-partnership memo and the clinical-trial packet.
7 Above-the-Fold Claims That Need Proof
Within 21 days, a team should be able to answer 7 questions: what the route funds, whether the source is open or expired, whether clinical trials are allowed, what budget rule applies, who is eligible in practice, what does not fit, and what route should be compared next.
According to NIH in the NOFO (opens in a new tab), this source should be treated as the authority for rules.
7 Route Checks Added June 2, 2026
Checked on June 2, 2026 against PAR-25-288 (opens in a new tab), the Grants.gov listing (opens in a new tab), USASpending.gov (opens in a new tab), PAR-25-289 (opens in a new tab), and Grants.gov (opens in a new tab).
| Check | What to confirm |
|---|---|
| Eligibility | Confirm the applicant, institution, and route rules for PAR-25-288 ED diversion R34 eligibility. |
| Source status | Verify the official listing, notices, due date, and expiration status. |
| Budget | Check award size, cost limits, match, or budget logic when the source provides it. |
| Evidence | Name the data, preliminary work, partner role, or implementation proof needed. |
| Bad fit | Stop if the project belongs in a nearby NIH or federal route. |
| Review criteria | Tie the first page to significance, approach, team, environment, and source-specific criteria. |
| Next action | Decide whether to draft, ask a program contact, or redirect. |
Final public checklist
- Confirm whether R34 is the right route or whether a nearby program fits better.
- Check budget, partner, match, or data-readiness constraints.
Sources
Next steps
Where to go next
These next pages help you move from research into a specific grant choice.
Open ED diversion R34 record
Check PAR-25-288, June and October 2026 dates, clinical-trial required status, R34 budget cap, and R01 companion route.
Compare family-health route
Use when the project is family-level intervention research rather than ED diversion pilot testing.
Compare clinical pilot R34
Use when the applicant needs a trial-pilot screen outside the ED mental-health route.
Find grants that fit you
Free eligibility check: answer 9 questions and see ranked matches with deadlines and fit reasons.
Frequently Asked Questions
What does PAR-25-288 fund?
It funds R34 pilot testing of patient-navigation emergency department diversion models for non-urgent mental health problems.
Are clinical trials required?
Yes. PAR-25-288 only accepts applications that propose clinical trials.
What budget applies?
NIH says R34 budgets are limited to $225,000 in direct costs per year and $450,000 over the three-year project period.
What is the next 2026 deadline?
The June 16, July 16 and October 16, 2026 dates have passed. NIH lists November 16, 2026 for resubmissions, then February 16, 2027 for new applications and March 16, 2027 for resubmissions. The notice expires January 8, 2028.
Who should skip this route?
Skip it if the project evaluates local practice, lacks mechanism testing, or is a fully powered effectiveness study better suited to the companion R01.
Last updated October 24, 2026. Corrected October 24, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.
Related Guides
Best Federal Grants for Mental Health Nonprofits 2026
12 FY2026 SAMHSA notices open to mental health nonprofits, who won FY2025 awards, plus foundation funders, state contracts, and Medicaid billing.
Community Mental Health Grants 2026: Block Grant Guide
Community mental health grants: how MHBG money reaches providers, SAMHSA CCBHC grants of up to $1 million a year, and the 31 Medicaid CCBHC states.
Mental Health Grants 2026: 15+ Programs & How to Apply
Mental health grants from SAMHSA, NIMH and HRSA: CCBHC grants up to $1 million a year, campus suicide prevention up to $125,000, eligibility, deadlines.
Grants to Start a Mental Health Practice in 2026
11+ ways to fund a new mental health practice: NHSC loan repayment, HRSA BHWET, SAMHSA CCBHC, state programs, and SBA microloans up to $50,000.
Mental Health Grants for Homeless 2026: Guide
HUD's FY2026 CoC NOFO offered $4.04 billion. PATH, CoC, HCH, and HUD-VASH eligibility, CABHI's status, and 6 application strategies explained.
Mental Health First Aid Grants 2026: Training Funding
5+ programs fund MHFA and gatekeeper training. SAMHSA grants, QPR funding, first responder mental health, and instructor costs.